Amy Paul, APRN

NPI: 1265002018
Total Payments
$6,253
2024 Payments
$2,201
Companies
23
Transactions
390
Medicare Patients
105
Medicare Billing
$20,134

Payment Breakdown by Category

Food & Beverage$6,127 (98.0%)
Education$125.33 (2.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,127 388 98.0%
Education $125.33 2 2.0%

Top Paying Companies

Company Total Records Latest Year
Neurocrine Biosciences, Inc. $807.68 69 $0 (2024)
Alkermes, Inc. $739.39 47 $0 (2024)
ABBVIE INC. $706.04 41 $0 (2024)
Teva Pharmaceuticals USA, Inc. $654.56 35 $0 (2024)
Janssen Pharmaceuticals, Inc $586.05 30 $0 (2024)
Otsuka America Pharmaceutical, Inc. $526.14 34 $0 (2024)
Axsome Therapeutics, Inc. $366.94 22 $0 (2024)
ITI, Inc. $360.17 24 $0 (2023)
Lundbeck LLC $318.35 19 $0 (2024)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $220.09 13 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,201 133 Alkermes, Inc. ($303.11)
2023 $2,586 160 Teva Pharmaceuticals USA, Inc. ($448.59)
2022 $1,340 95 Neurocrine Biosciences, Inc. ($246.65)
2021 $126.19 2 JAZZ PHARMACEUTICALS INC. ($102.54)

All Payment Transactions

390 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
12/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.40 General
Category: NEUROSCIENCE
12/16/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $30.88 General
Category: Psychiatry/Psychology
12/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $6.43 General
Category: Neuropsychiatry
12/11/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $27.81 General
Category: PSYCHIATRY
12/11/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $20.10 General
Category: PSYCHIATRY
12/10/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $21.43 General
Category: Neuropsychiatry
12/10/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $11.34 General
Category: CNS
12/04/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $25.39 General
Category: CNS
12/03/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $15.63 General
Category: Neuroscience
12/03/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $8.13 General
Category: CNS Stimulant for ADHD
12/02/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $32.99 General
Category: Neuropsychiatry
12/02/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $8.18 General
Category: Neuropsychiatry
12/02/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $5.17 General
Category: Neuropsychiatry
11/27/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $12.01 General
Category: Psychology/Psychiatric
11/26/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $17.03 General
Category: Psychiatry/Psychology
11/25/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $6.50 General
Category: Neuropsychiatry
11/20/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $20.64 General
Category: Central Nervous System
11/19/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $18.97 General
Category: PSYCHIATRY
11/16/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $20.10 General
Category: PSYCHIATRY
11/13/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $16.46 General
Category: PSYCHIATRY
11/12/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $18.36 General
Category: CNS
11/11/2024 Vanda Pharmaceuticals Inc. HETLIOZ (Drug), FANAPT Food and Beverage In-kind items and services $20.12 General
Category: NON-24-HOUR SLEEP-WAKE DISORDER
11/11/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA Food and Beverage In-kind items and services $15.18 General
Category: PSYCHIATRY
11/06/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $17.57 General
Category: PSYCHIATRY
11/05/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.96 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 63 186 $37,818 $14,015
2022 2 42 64 $14,847 $6,118
Total Patients
105
Total Services
250
Medicare Billing
$20,134
Procedure Codes
4

All Medicare Procedures & Services

4 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 39 162 $30,618 $11,374 37.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 24 24 $7,200 $2,641 36.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 23 23 $6,900 $3,092 44.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 19 41 $7,947 $3,027 38.1%

About Amy Paul, APRN

Amy Paul, APRN is a Psychiatric/Mental Health healthcare provider based in Alexandria, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2021. The National Provider Identifier (NPI) number assigned to this provider is 1265002018.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Paul, APRN has received a total of $6,253 in payments from pharmaceutical and medical device companies, with $2,201 received in 2024. These payments were reported across 390 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($6,127).

As a Medicare-enrolled provider, Paul has provided services to 105 Medicare beneficiaries, totaling 250 services with total Medicare billing of $20,134. Data is available for 2 years (2022–2023), covering 4 distinct procedure/service records.

Practice Information

  • Specialty Psychiatric/Mental Health
  • Location Alexandria, LA
  • Active Since 06/24/2021
  • Last Updated 06/25/2021
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • NPI Number 1265002018

Products in Payments

  • INGREZZA (Drug) $807.68
  • VRAYLAR (Drug) $706.04
  • ARISTADA (Drug) $689.34
  • REXULTI (Drug) $625.74
  • CAPLYTA (Drug) $580.26
  • Auvelity (Drug) $347.06
  • INVEGA SUSTENNA (Drug) $298.65
  • SPRAVATO (Drug) $287.40
  • Austedo XR (Drug) $260.89
  • Azstarys (Drug) $164.91
  • ABILIFY MAINTENA (Drug) $150.63
  • TRINTELLIX (Drug) $148.65
  • AUSTEDO (Drug) $140.19
  • SUBLOCADE (Drug) $119.21
  • AJOVY (Biological) $109.87
  • SUNOSI (Drug) $102.54
  • LATUDA (Drug) $91.90
  • UZEDY (Drug) $67.12
  • ABILIFY ASIMTUFII (Drug) $63.65
  • NUPLAZID (Drug) $63.51

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Alexandria